Mendelian randomization analyses link insomnia with higher generalized epilepsy risk, suggesting sleep traits as modifiable targets for seizure control and personalized epilepsy management strategies ...
Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into ...
Covenant Health recently announced another addition to its treatment options for neurological disorders. Responsive Neurostimulation (RNS) is bringing new hope to patients across West Texas and ...
Detailed price information for Praxis Precision Medicines Inc (PRAX-Q) from The Globe and Mail including charting and trades.
LEQEMBI IQLIK, if approved for initiation dosing, would be the first and only anti-amyloid treatment to offer at-home injection from the start of therapy ...
Epilepsy is when the brain has an electrical misfire that causes multiple seizures. And depending on where the misfire takes place, the seizure will have different effects, such as freezing you or ...
The risk for a first-ever epileptic seizure after cerebral cavernous malformations is low, with younger age and initial ...
Although some outcomes showed small to medium effect sizes, these results must be interpreted cautiously given the presence ...
The performance of skilled behaviors requires a balance between consistency and adaptability. Although the neural mechanisms that regulate this balance have been extensively studied at systems and ...
Meta-analysis indicates that network-targeted noninvasive brain stimulation consistently enhances memory function supported by the hippocampal network, thus providing robust evidence that specific ...